Ceapro earns $17,768 in Q1 2017

... Read more

CECO Environmental Corp. Reports First Quarter 2016

... Read more

CECO Environmental Corp. Reports First Quarter 2016

... Read more

CEL-SCI Reports March 2014 is Record Month for Patient Enrollment in Phase III Head and Neck Cancer Trial

... Read more

U.S. FDA Removes Clinical Hold on CEL-SCI ’s Phase 3 Head & Neck Cancer

... Read more

CEL-SCI Granted European Patent for Multikine ’s Mechanism of Action in

... Read more

Celator®

... Read more

Celator®

... Read more

Celator®

... Read more

Celator Announces Phase 3 Trial for VYXEOS™ (CPX-351) in Patients

... Read more